2009 IEEE International Ultrasonics Symposium 2009
DOI: 10.1109/ultsym.2009.5442058
|View full text |Cite
|
Sign up to set email alerts
|

Ultrasonic delivery of a chemotherapeutic agent using acoustic droplet vaporization (ADV)

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3

Citation Types

0
3
0

Year Published

2012
2012
2014
2014

Publication Types

Select...
2
1

Relationship

0
3

Authors

Journals

citations
Cited by 3 publications
(3 citation statements)
references
References 5 publications
0
3
0
Order By: Relevance
“…This phenomenon, termed acoustic droplet vaporization (ADV) 2 , has been proposed a number of in vitro and in vivo applications such as vascular occlusion 3 , diagnostic imaging 4,5 , ultrasound-mediated tissue ablation 6 and drug delivery 7,8 . In vitro studies have shown that the smaller the droplet diameter, the higher the vaporization threshold and high acoustic pressures are required for vaporization 9,10 . Although a nanometer-scale droplet has advantages of stability at physiological temperature and efficient for extravasation into tissue 3,8 , it may require pressures higher than diagnostic ultrasound machines provide, increasing the potential for unwanted bioeffects 11 .…”
Section: Introductionmentioning
confidence: 99%
“…This phenomenon, termed acoustic droplet vaporization (ADV) 2 , has been proposed a number of in vitro and in vivo applications such as vascular occlusion 3 , diagnostic imaging 4,5 , ultrasound-mediated tissue ablation 6 and drug delivery 7,8 . In vitro studies have shown that the smaller the droplet diameter, the higher the vaporization threshold and high acoustic pressures are required for vaporization 9,10 . Although a nanometer-scale droplet has advantages of stability at physiological temperature and efficient for extravasation into tissue 3,8 , it may require pressures higher than diagnostic ultrasound machines provide, increasing the potential for unwanted bioeffects 11 .…”
Section: Introductionmentioning
confidence: 99%
“…Emulsions are drawing increased attention, and so-called phase-shift emulsions (generally containing low boiling point fluorocarbons) can give ultrasound-triggered release when emulsion droplets vaporize in response to insonation. 17 Ganta and Amiji 18 have used a combination of paclitaxel and curcumin in nanoemulsion formulations to overcome multidrug resistance in SKOV3 TR ovarian adenocarcinoma cells.…”
Section: Introductionmentioning
confidence: 99%
“…Incorporation of poly(ethylene glycol)-containing surfactants appears to enhance the sensitivity of lipid-based carriers to sound,16 possibly by interfering with the “healing” of membrane defects. Emulsions are drawing increased attention, and so-called phase-shift emulsions (generally containing low boiling point fluorocarbons) can give ultrasound-triggered release when emulsion droplets vaporize in response to insonation 17. Ganta and Amiji18 have used a combination of paclitaxel and curcumin in nanoemulsion formulations to overcome multidrug resistance in SKOV3 TR ovarian adenocarcinoma cells.…”
Section: Introductionmentioning
confidence: 99%